Bausch Health Companies Inc. (BHC) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Other		986.0	937.0	995.0	1,127.0	1,257.0		1,200.0
Italy		80.0	71.0	85.0		78.0
Other		7,368.0	7,019.0	7,521.0	7,253.0	7,389.0		9,247.0
Total revenues [+]	8,124.0	8,434.0	8,027.0	8,601.0	8,380.0	8,724.0	9,674.0	10,447.0
Royalties								155.0
Products	8,046.0							10,292.0
Other	78.0
Revenue growth [+]	-3.7%	5.1%	-6.7%	2.6%	-3.9%	-9.8%	-7.4%	27.3%
Other		5.2%	-5.8%	-11.7%	-10.3%
Italy		12.7%	-16.5%
Cost of goods sold [+]	2,336.0	2,436.0	2,239.0	2,340.0	2,341.0	2,566.0	2,598.0	2,585.0
Cost of product sales								2,532.0
Cost of services								53.0
Cost of licenses and services								53.0
Gross profit	5,788.0	5,998.0	5,788.0	6,261.0	6,039.0	6,158.0	7,076.0	7,862.0
Gross margin	71.2%	71.1%	72.1%	72.8%	72.1%	70.6%	73.1%	75.3%
Selling, general and administrative	2,625.0	2,624.0	2,367.0	2,554.0	2,473.0	2,582.0	2,810.0	2,700.0
Research and development	529.0	465.0	452.0	471.0	413.0	361.0	421.0	334.0
Other operating expenses	1,356.0	1,737.0	2,099.0	3,323.0	2,633.0	2,631.0	2,759.0	2,529.0
EBITDA [+]	2,493.0	2,724.0	2,695.0	1,988.0	3,339.0	3,442.0	3,952.0	4,766.0
EBITDA growth	-8.5%	1.1%	35.6%	-40.5%	-3.0%	-12.9%	-17.1%	14.9%
EBITDA margin	30.7%	32.3%	33.6%	23.1%	39.8%	39.5%	40.9%	45.6%
Depreciation		177.0	180.0	178.0	175.0	168.0	193.0	210.0
EBITA	2,493.0	2,547.0	2,515.0	1,810.0	3,164.0	3,274.0	3,759.0	4,556.0
EBITA margin	30.7%	30.2%	31.3%	21.0%	37.8%	37.5%	38.9%	43.6%
Amortization of intangibles	1,215.0	1,375.0	1,645.0	1,897.0	2,644.0	2,690.0	2,673.0	2,257.0
EBIT [+]	1,278.0	1,172.0	870.0	-87.0	520.0	584.0	1,086.0	2,299.0
EBIT growth	9.0%	34.7%	-1100.0%	-116.7%	-11.0%	-46.2%	-52.8%	-9.3%
EBIT margin	15.7%	13.9%	10.8%	-1.0%	6.2%	6.7%	11.2%	22.0%
Non-recurring items [+]	824.0	722.0	194.0	116.0	2,904.0	482.0	1,652.0	772.0
Asset impairment	824.0	703.0	114.0	75.0	2,890.0	714.0	1,499.0	304.0
Restructuring charges					22.0	52.0	132.0	339.0
Unusual expense		11.0	48.0		-9.0	-289.0	-13.0	23.0
In-process research & development		8.0	32.0	41.0	1.0	5.0	34.0	106.0
Interest expense, net [+]	1,450.0	1,419.0	1,521.0	1,600.0	1,674.0	1,828.0	1,828.0	1,559.0
Interest expense	1,464.0	1,426.0	1,534.0	1,612.0	1,685.0	1,840.0	1,836.0	1,563.0
Interest income	14.0	7.0	13.0	12.0	11.0	12.0	8.0	4.0
Other income (expense), net [+]	867.0	-55.0	-89.0	-34.0	-96.0	-15.0	-41.0	-123.0
Gain (loss) on debt retirement	875.0	-62.0	-59.0	-42.0	-119.0	-122.0		-20.0
Gain (loss) on foreign currency transactions		7.0	-30.0	8.0	23.0	107.0	-41.0	-103.0
Pre-tax income	-129.0	-1,024.0	-934.0	-1,837.0	-4,154.0	-1,741.0	-2,435.0	-155.0
Income taxes	83.0	-87.0	-375.0	-54.0	-10.0	-4,145.0	-27.0	133.0
Tax rate		8.5%	40.1%	2.9%	0.2%	238.1%	1.1%
Minority interest	-13.0	11.0	1.0	5.0	-4.0		-1.0	4.0
Net income	-212.0	-948.0	-560.0	-1,788.0	-4,148.0	2,404.0	-2,409.0	-292.0
Net margin	-2.6%	-11.2%	-7.0%	-20.8%	-49.5%	27.6%	-24.9%	-2.8%

Basic EPS [+]		($2.64)	($1.58)	($5.08)	($11.81)	$6.86	($6.94)	($0.85)
Growth		67.4%	-68.9%	-57.0%	-272.0%	-199.0%	714.1%	-132.4%
Diluted EPS [+]		($2.64)	($1.58)	($5.08)	($11.81)	$6.83	($6.94)	($0.85)
Growth		67.4%	-68.9%	-57.0%	-272.8%	-198.5%	714.1%	-133.0%


Shares outstanding (basic) [+]		358.9	355.0	352.1	351.3	350.2	347.3	342.7
Growth		1.1%	0.8%	0.2%	0.3%	0.8%	1.3%	2.2%
Shares outstanding (diluted) [+]		358.9	355.0	352.1	351.3	351.8	347.3	342.7
Growth		1.1%	0.8%	0.2%	-0.1%	1.3%	1.3%	0.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.